DLL4 and B-cell chronic lymphocytic leukemia: Importantly, the anti-Notch1 antibody significantly reversed both CXCR4 gene expression levels (p < 0.01) and chemotaxis in DLL4-stimulated NOTCH1-mutated CLL (p < 0.05).